Thomson puts med ed biz on the block

Share this article:
Thomson Medical Education (TME), whose three businesses comprise the world's largest med ed organization,will be sold.

Thomson announced the sale last week as it posted second-quarter earnings of $171 million, down from $301 million a year earlier when there was a big one-time tax gain, and revenues of $2.1 billion, up 7% from the prior-year period. Thomson also introduced a “business optimization” plan designed to save about $300 million from the holding company's costs by 2009.

TME, part of the Scientific and Healthcare group, accounted for $97 million in revenue last year and will be shed in an ongoing sale of minor businesses.

“We found that [TME] doesn't fit well with our long-term growth strategy” of providing applications and services to healthcare professionals, insurers and employers, said Kyle Christensen, a spokesman.

The decision to divest TME follows the departure of top executives Jeff MacDonald, former head of the med ed unit, and Marty Cearnal, its chief strategy officer. MacDonald was replaced by Dik Barsamian, division EVP, earlier this year.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...